Copyright Reports & Markets. All rights reserved.

Global BCG Vaccine for Tuberculosis (TB) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global BCG Vaccine for Tuberculosis (TB) Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Immune Type
    • 1.3.3 Therapy Type
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global BCG Vaccine for Tuberculosis (TB) Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Global BCG Vaccine for Tuberculosis (TB) Market Size & Forecast
    • 1.5.1 Global BCG Vaccine for Tuberculosis (TB) Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global BCG Vaccine for Tuberculosis (TB) Sales Quantity (2020-2031)
    • 1.5.3 Global BCG Vaccine for Tuberculosis (TB) Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.1.4 Merck BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Japan BCG Lab
    • 2.2.1 Japan BCG Lab Details
    • 2.2.2 Japan BCG Lab Major Business
    • 2.2.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.2.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Japan BCG Lab Recent Developments/Updates
  • 2.3 China National Biotec
    • 2.3.1 China National Biotec Details
    • 2.3.2 China National Biotec Major Business
    • 2.3.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.3.4 China National Biotec BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 China National Biotec Recent Developments/Updates
  • 2.4 AJ Vaccines
    • 2.4.1 AJ Vaccines Details
    • 2.4.2 AJ Vaccines Major Business
    • 2.4.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.4.4 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 AJ Vaccines Recent Developments/Updates
  • 2.5 Serum Institute of India
    • 2.5.1 Serum Institute of India Details
    • 2.5.2 Serum Institute of India Major Business
    • 2.5.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.5.4 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Serum Institute of India Recent Developments/Updates
  • 2.6 BioFarma
    • 2.6.1 BioFarma Details
    • 2.6.2 BioFarma Major Business
    • 2.6.3 BioFarma BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.6.4 BioFarma BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 BioFarma Recent Developments/Updates
  • 2.7 GSBPL
    • 2.7.1 GSBPL Details
    • 2.7.2 GSBPL Major Business
    • 2.7.3 GSBPL BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.7.4 GSBPL BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 GSBPL Recent Developments/Updates
  • 2.8 Biomed Lublin
    • 2.8.1 Biomed Lublin Details
    • 2.8.2 Biomed Lublin Major Business
    • 2.8.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.8.4 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Biomed Lublin Recent Developments/Updates
  • 2.9 Taj Pharmaceuticals
    • 2.9.1 Taj Pharmaceuticals Details
    • 2.9.2 Taj Pharmaceuticals Major Business
    • 2.9.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.9.4 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Taj Pharmaceuticals Recent Developments/Updates
  • 2.10 Ataulpho de Paiva
    • 2.10.1 Ataulpho de Paiva Details
    • 2.10.2 Ataulpho de Paiva Major Business
    • 2.10.3 Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.10.4 Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Ataulpho de Paiva Recent Developments/Updates
  • 2.11 ANLIS Malbran
    • 2.11.1 ANLIS Malbran Details
    • 2.11.2 ANLIS Malbran Major Business
    • 2.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.11.4 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 ANLIS Malbran Recent Developments/Updates
  • 2.12 Fundação Ataulpho de Paiva
    • 2.12.1 Fundação Ataulpho de Paiva Details
    • 2.12.2 Fundação Ataulpho de Paiva Major Business
    • 2.12.3 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.12.4 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Fundação Ataulpho de Paiva Recent Developments/Updates
  • 2.13 BB-NCIPD
    • 2.13.1 BB-NCIPD Details
    • 2.13.2 BB-NCIPD Major Business
    • 2.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.13.4 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 BB-NCIPD Recent Developments/Updates
  • 2.14 Torlakinstitut
    • 2.14.1 Torlakinstitut Details
    • 2.14.2 Torlakinstitut Major Business
    • 2.14.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.14.4 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Torlakinstitut Recent Developments/Updates
  • 2.15 IVAC – Institute of Vaccines and Medical Biologicals
    • 2.15.1 IVAC – Institute of Vaccines and Medical Biologicals Details
    • 2.15.2 IVAC – Institute of Vaccines and Medical Biologicals Major Business
    • 2.15.3 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.15.4 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
  • 2.16 Institut Pasteur de Tunis
    • 2.16.1 Institut Pasteur de Tunis Details
    • 2.16.2 Institut Pasteur de Tunis Major Business
    • 2.16.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product and Services
    • 2.16.4 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Institut Pasteur de Tunis Recent Developments/Updates

3 Competitive Environment: BCG Vaccine for Tuberculosis (TB) by Manufacturer

  • 3.1 Global BCG Vaccine for Tuberculosis (TB) Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Manufacturer (2020-2025)
  • 3.3 Global BCG Vaccine for Tuberculosis (TB) Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of BCG Vaccine for Tuberculosis (TB) by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 BCG Vaccine for Tuberculosis (TB) Manufacturer Market Share in 2024
    • 3.4.3 Top 6 BCG Vaccine for Tuberculosis (TB) Manufacturer Market Share in 2024
  • 3.5 BCG Vaccine for Tuberculosis (TB) Market: Overall Company Footprint Analysis
    • 3.5.1 BCG Vaccine for Tuberculosis (TB) Market: Region Footprint
    • 3.5.2 BCG Vaccine for Tuberculosis (TB) Market: Company Product Type Footprint
    • 3.5.3 BCG Vaccine for Tuberculosis (TB) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global BCG Vaccine for Tuberculosis (TB) Market Size by Region
    • 4.1.1 Global BCG Vaccine for Tuberculosis (TB) Sales Quantity by Region (2020-2031)
    • 4.1.2 Global BCG Vaccine for Tuberculosis (TB) Consumption Value by Region (2020-2031)
    • 4.1.3 Global BCG Vaccine for Tuberculosis (TB) Average Price by Region (2020-2031)
  • 4.2 North America BCG Vaccine for Tuberculosis (TB) Consumption Value (2020-2031)
  • 4.3 Europe BCG Vaccine for Tuberculosis (TB) Consumption Value (2020-2031)
  • 4.4 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Consumption Value (2020-2031)
  • 4.5 South America BCG Vaccine for Tuberculosis (TB) Consumption Value (2020-2031)
  • 4.6 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global BCG Vaccine for Tuberculosis (TB) Sales Quantity by Type (2020-2031)
  • 5.2 Global BCG Vaccine for Tuberculosis (TB) Consumption Value by Type (2020-2031)
  • 5.3 Global BCG Vaccine for Tuberculosis (TB) Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global BCG Vaccine for Tuberculosis (TB) Sales Quantity by Application (2020-2031)
  • 6.2 Global BCG Vaccine for Tuberculosis (TB) Consumption Value by Application (2020-2031)
  • 6.3 Global BCG Vaccine for Tuberculosis (TB) Average Price by Application (2020-2031)

7 North America

  • 7.1 North America BCG Vaccine for Tuberculosis (TB) Sales Quantity by Type (2020-2031)
  • 7.2 North America BCG Vaccine for Tuberculosis (TB) Sales Quantity by Application (2020-2031)
  • 7.3 North America BCG Vaccine for Tuberculosis (TB) Market Size by Country
    • 7.3.1 North America BCG Vaccine for Tuberculosis (TB) Sales Quantity by Country (2020-2031)
    • 7.3.2 North America BCG Vaccine for Tuberculosis (TB) Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe BCG Vaccine for Tuberculosis (TB) Sales Quantity by Type (2020-2031)
  • 8.2 Europe BCG Vaccine for Tuberculosis (TB) Sales Quantity by Application (2020-2031)
  • 8.3 Europe BCG Vaccine for Tuberculosis (TB) Market Size by Country
    • 8.3.1 Europe BCG Vaccine for Tuberculosis (TB) Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe BCG Vaccine for Tuberculosis (TB) Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Market Size by Region
    • 9.3.1 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America BCG Vaccine for Tuberculosis (TB) Sales Quantity by Type (2020-2031)
  • 10.2 South America BCG Vaccine for Tuberculosis (TB) Sales Quantity by Application (2020-2031)
  • 10.3 South America BCG Vaccine for Tuberculosis (TB) Market Size by Country
    • 10.3.1 South America BCG Vaccine for Tuberculosis (TB) Sales Quantity by Country (2020-2031)
    • 10.3.2 South America BCG Vaccine for Tuberculosis (TB) Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Market Size by Country
    • 11.3.1 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 BCG Vaccine for Tuberculosis (TB) Market Drivers
  • 12.2 BCG Vaccine for Tuberculosis (TB) Market Restraints
  • 12.3 BCG Vaccine for Tuberculosis (TB) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of BCG Vaccine for Tuberculosis (TB) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of BCG Vaccine for Tuberculosis (TB)
  • 13.3 BCG Vaccine for Tuberculosis (TB) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 BCG Vaccine for Tuberculosis (TB) Typical Distributors
  • 14.3 BCG Vaccine for Tuberculosis (TB) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global BCG Vaccine for Tuberculosis (TB) market size was valued at US$ 82.7 million in 2024 and is forecast to a readjusted size of USD 101 million by 2031 with a CAGR of 3.0% during review period.
    BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
    Key driver for the BCG vaccine market is the increasing prevalence of tuberculosis (TB) in various regions, especially in countries with lower healthcare resources. Rising TB cases have driven governments and global health organizations, like the World Health Organization (WHO), to actively promote TB vaccination programs to curb the spread of the disease. Efforts to increase BCG vaccine coverage in high-risk areas and the focus on reducing childhood TB have further propelled demand, creating a sustained need for vaccine supply and development.
    A major challenge in the BCG vaccine market is the variability in its effectiveness, especially against pulmonary TB in adults. This inconsistency in protection levels has led to cautious adoption in some regions with lower TB rates. Moreover, the emergence of multi-drug-resistant TB strains complicates the market, as BCG is not effective against these resistant strains. These limitations emphasize the need for alternative vaccines or treatments, affecting the long-term outlook for BCG as a standalone solution in TB prevention.
    This report is a detailed and comprehensive analysis for global BCG Vaccine for Tuberculosis (TB) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global BCG Vaccine for Tuberculosis (TB) market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
    Global BCG Vaccine for Tuberculosis (TB) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
    Global BCG Vaccine for Tuberculosis (TB) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
    Global BCG Vaccine for Tuberculosis (TB) market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for BCG Vaccine for Tuberculosis (TB)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global BCG Vaccine for Tuberculosis (TB) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, BioFarma, GSBPL, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    BCG Vaccine for Tuberculosis (TB) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Immune Type
    Therapy Type
    Market segment by Application
    Hospitals
    Clinics
    Others
    Major players covered
    Merck
    Japan BCG Lab
    China National Biotec
    AJ Vaccines
    Serum Institute of India
    BioFarma
    GSBPL
    Biomed Lublin
    Taj Pharmaceuticals
    Ataulpho de Paiva
    ANLIS Malbran
    Fundação Ataulpho de Paiva
    BB-NCIPD
    Torlakinstitut
    IVAC – Institute of Vaccines and Medical Biologicals
    Institut Pasteur de Tunis
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe BCG Vaccine for Tuberculosis (TB) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of BCG Vaccine for Tuberculosis (TB), with price, sales quantity, revenue, and global market share of BCG Vaccine for Tuberculosis (TB) from 2020 to 2025.
    Chapter 3, the BCG Vaccine for Tuberculosis (TB) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the BCG Vaccine for Tuberculosis (TB) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and BCG Vaccine for Tuberculosis (TB) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of BCG Vaccine for Tuberculosis (TB).
    Chapter 14 and 15, to describe BCG Vaccine for Tuberculosis (TB) sales channel, distributors, customers, research findings and conclusion.

    Buy now